Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118536) titled 'Clinical characterization of taxanes chemotherapeutic regiments-induced peripheral neurotoxicity and establishment of a risk model' on Feb. 6.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The First Affiliated hospital of Jinzhou Medical University
Condition:
Taxanes chemotherapeutic regiments-induced peripheral neurotoxicity
Intervention:
Cohort 1 (Patients who have been pathologically diagnosed with a malignant solid tumor and plan to receive taxane chemotherapy):None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-24
Target Sample Size...